Treatise:Mechanism and Practice

Effects of iron supplementation on thyroid function and autoantibodies in pregnant women with thyroid dysfunction

  • Haiyou WANG ,
  • Xueting LIU ,
  • Wenhuan LIAO ,
  • Xiaoyu WANG ,
  • Zhibao CHENG ,
  • Yujie XU ,
  • Yixing GAO ,
  • Jingyuan XIONG ,
  • Yunhui GONG ,
  • Guo CHENG
Expand
  • 1.West China School of Public Health and West China Fourth Hospital,Sichuan University,Chengdu 610041,Sichuan,China
    2.West China Women and Children Nutrition Center,West China Second Hospital,Sichuan University,Chengdu 610041,Sichuan,China
    3.Key Laboratory of Birth Defects and Related Diseases of Women and Children,Sichuan University,Ministry of Education,Chengdu 610041,Sichuan,China
    4.Department of Oncology,the Second Affiliated Hospital of Army Medical University,Chongqing 400038,Chongqing,China
    5.Key Laboratory of Active Health and Food Nutrition Safety of Sichuan Province,Chengdu 610041,Sichuan,China
    6.Department of Obstetrics,West China Second University Hospital,Sichuan University,Chengdu 610041,Sichuan,China
    7.Key Laboratory of Children's Drugs of Sichuan Province,Chengdu 610041,Sichuan,China

Received date: 2026-05-19

  Revised date: 2026-06-17

  Accepted date: 2026-06-18

  Online published: 2026-08-13

Abstract

Objective To investigate the effects of iron supplementation on thyroid function indices and thyroid-related autoantibodies in pregnant women with thyroid dysfunction under different iron nutritional statuses. Methods This retrospective cohort study recruited 353 pregnant women with thyroid dysfunction who registered for antenatal care at a tertiary Grade-A maternal and child health hospital in Chengdu, China, from November 2024 to August 2025. Based on the baseline iron nutritional status (iron deficiency vs. iron sufficiency) and exposure to iron supplementation, the participants were naturally divided into four groups. The changes in thyroid function indices and autoantibody levels before and after iron supplementation were compared among the groups. Multiple linear regression models were used to analyze the associations between iron supplementation and changes in thyroid function indices and autoantibody levels under different iron nutritional statuses. Results Among iron-deficient pregnant women with thyroid dysfunction, statistically significant differences were detected between the iron-supplemented and non-supplemented groups in free thyroxine (FT4) [β(95%CI): -4.75 (-7.73 - -1.76), P = 0.002], thyroid-stimulating hormone (TSH) [β(95%CI): -1.84 (-3.49 - -0.18), P = 0.030], and anti-thyroid peroxidase antibody (TPOAb) [β(95%CI): -271.33 (-423.84 - -118.82), P < 0.001]. Among iron-sufficient pregnant women with thyroid dysfunction, iron supplementation was linked to a reduction in anti-thyroglobulin antibody (TGAb) levels [β(95%CI): -41.74 (-75.69 - -7.79), P = 0.016]. No associations were identified between iron supplementation and triiodothyronine (T3), thyroxine (T4), or free triiodothyronine (FT3). Conclusions In pregnant women with thyroid dysfunction, iron supplementation is associated with specific changes in thyroid function parameters and autoantibody levels. Moreover, prophylactic iron supplementation effectively mitigates thyroid autoimmune responses in iron-sufficient pregnant women.

Cite this article

Haiyou WANG , Xueting LIU , Wenhuan LIAO , Xiaoyu WANG , Zhibao CHENG , Yujie XU , Yixing GAO , Jingyuan XIONG , Yunhui GONG , Guo CHENG . Effects of iron supplementation on thyroid function and autoantibodies in pregnant women with thyroid dysfunction[J]. The Journal of Practical Medicine, 2026 , 42(15) : 2779 -2785 . DOI: 10.3969/j.issn.1006-5725.2026.15.014

References

[1] BROWN E D L, OBENG-GYASI B, HALL J E, et al. The thyroid hormone axis and female reproduction[J]. Int J Mol Sci, 2023, 24(12): 9815. doi:10.3390/ijms24129815 .
[2] SA?LAM E, ERIS YAL?IN S, ?ZLER M R, et al. Trimester-specific thyroid function markers and gestational diabetes risk: Evidence from a tertile-based cohort of euthyroid pregnancies[J]. J Matern Fetal Neonatal Med, 2025, 38(1): 2535467. doi:10.1080/14767058.2025.2535467 .
[3] SHIBI ANILKUMAR A, MARIAM THOMAS S, VEERABATHIRAN R. Autoimmune thyroid disease in pregnancy: Clinical implications for miscarriage risk[J]. Endocr Res, 2026, 51(1): 1-14. doi:10.1080/07435800.2025.2575170 .
[4] 郑雪琴, 胡英. 妊娠相关蛋白A联合甲状腺过氧化物酶抗体对亚临床甲状腺功能减退合并妊娠期高血压患者的妊娠结局预测[J]. 实用医学杂志, 2026, 42(8): 1444-1449. doi:10.3969/ j.issn.1006-5725.2026.08.019 .
[5] 蒋艳苹, 袁巍, 王淑琼, 等. 基于甲状腺功能、甲状腺自身抗体分析妊娠期孕妇碘营养异常的影响因素[J]. 实用医学杂志, 2025, 41(16): 2549-2555. doi:10.3969/j.issn.1006-5725.2025. 16.016 .
[6] SHULHAI A M, ROTONDO R, PETRAROLI M, et al. The role of nutrition on thyroid function[J]. Nutrients, 2024, 16(15): 2496. doi:10.3390/nu16152496 .
[7] ZYCH-KREKORA K, SYLWESTRZAK O, KREKORA M. The critical role of iron in pregnancy, puerperium, and fetal development[J]. J Clin Med, 2025, 14(10): 3482. doi:10.3390/jcm14103482 .
[8] 李光辉, 王欣. 孕妇和乳母营养[M]. 北京: 化学工业出版社, 2024: 438.
[9] WORLD HEALTH ORGANIZAITION. Daily Iron and Folic Acid Supplementation During Pregnancy.2024[EB/OL].(2024-07-26)[2026-05-19]. .
[10] 陈颖, 黎青, 蔡针针, 等. 孕中期孕妇铁营养状况与甲状腺功能的相关性[J]. 江苏医药, 2019, 45(1): 25-27. doi:10.19460/ j.cnki.0253-3685.2019.01.007 .
[11] GAROFALO V, CONDORELLI R A, CANNARELLA R, et al. Relationship between iron deficiency and thyroid function: A systematic review and meta-analysis[J]. Nutrients, 2023, 15(22): 4790. doi:10.3390/nu15224790 .
[12] 田宗源, 王雪冉, 刘瑞霞. 妊娠期亚临床甲状腺功能减退与血清铁蛋白关系的研究进展[J]. 现代妇产科进展, 2023, 32(6): 455-457. doi:10.13283/j.cnki.xdfckjz.2023.06.010 .
[13] GUPTA N, NARAYAN A, TONK R S, et al. Study of relationship between iron deficiency and thyroid function in pregnant females[J]. Cureus, 2022, 14(12): e32411. doi:10.7759/cureus.32411 .
[14] 中华医学会围产医学分会. 妊娠期铁缺乏和缺铁性贫血诊治指南[J]. 中华围产医学杂志, 2014, 17(7): 451-454. doi:10.3760/cma.j.issn.1007-9408.2014.07.006 .
[15] 中华医学会血液学分会红细胞疾病(贫血)学组. 铁缺乏症和缺铁性贫血诊治和预防的多学科专家共识(2022年版)[J]. 中华医学杂志, 2022, 102(41): 3246-3256. doi:10.3760/cma.j.cn112137-20220621-01361 .
[16] PARSAEI M, DASHTKOOHI M, AMIRKHALILI E, et al. Association of iron status indicators with thyroid hormone concentrations during pregnancy: A systematic review and meta-analysis[J]. Front Endocrinol, 2025, 16: 1533169. doi:10.3389/fendo. 2025.1533169 .
[17] ABADI K K, JAMA A H, LEGESSE A Y, et al. Prevalence of hypothyroidism in pregnancy and its associations with adverse pregnancy outcomes among pregnant women in a general hospital: A cross sectional study[J]. Int J Women′s Health, 2023, 15: 1481-1490. doi:10.2147/IJWH.S429611 .
[18] CROCE L, ROTONDI M, RUGGERI R M. Modern challenges of iodine nutrition: Vegan and vegetarian diets[J]. Front Endocrinol, 2025, 16: 1537208. doi:10.3389/fendo.2025.1537208 .
[19] TANG J, SHAN S, LI F, et al. Effects of vitamin D supplementation on autoantibodies and thyroid function in patients with Hashimoto′s thyroiditis: A systematic review and meta-analysis[J]. Medicine, 2023, 102(52): e36759. doi:10.1097/md. 0000000000036759 .
[20] OSINGA J A J, LIU Y, M?NNIST? T, et al. Risk factors for thyroid dysfunction in pregnancy: An individual participant data meta-analysis[J]. Thyroid?, 2024, 34(5): 646-658. doi:10.1089/thy.2023.0646 .
[21] WANG F, ZHANG Y, YUAN Z, et al. The association between iron status and thyroid hormone levels during pregnancy[J]. J Trace Elem Med Biol, 2022, 74: 127047. doi:10.1016/j.jtemb. 2022.127047 .
[22] VINAYAGAMOORTHI R, DHIMAN P, KOLLIPAKA R, et al. Association of hypothyroidism with low serum ferritin levels and iron-deficiency Anemia During the first trimester of pregnancy[J]. Cureus, 2022, 14(8): e28307. doi:10.7759/cureus.28307 .
[23] RALLI M, ANGELETTI D, FIORE M, et al. Hashimoto’s thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation[J]. Autoimmun Rev, 2020, 19(10): 102649. doi:10.1016/j.autrev.2020.102649 .
[24] KAUR J, JIALAL I. Hashimoto Thyroiditis[M]. Treasure Island (FL): StatPearls Publishing, 2026.
[25] CARAFONE L, KNUTSON A J, GIGLIOTTI B J. A review of autoimmune thyroid diseases and their complex interplay with female fertility[J]. Semin Reprod Med, 2024, 42(3): 178-192. doi:10.1055/s-0044-1795160 .
[26] POPA E C, MAGHIAR L, MAGHIAR T A, et al. Hashimoto’s thyroiditis and female fertility: Endocrine, immune, and microbiota perspectives in assisted reproduction—a narrative review[J]. Biomedicines, 2025, 13(6): 1495. doi:10.3390/biomedicines13061495 .
[27] WANG L, ZHU X, et al. Hashimoto’s thyroiditis: From pathogenesis to clinical management[J]. Front Endocrinol, 2026, 17: 1729316. doi:10.3389/fendo.2026.1729316 .
[28] LUO Y, ZENG H, YE Y, et al. Associations of metal profiles in blood with thyroiditis: A cross-sectional study[J]. Environ Sci Pollut Res, 2023, 30(8): 21072-21080. doi:10.1007/s11356-022-23625-1 .
[29] BOGOVI? CRN?I? T, ?URKO-COFEK B, BATI?I? L, et al. Autoimmune thyroid disease and pregnancy: The interaction between genetics, epigenetics and environmental factors[J]. J Clin Med, 2025, 14(1): 190. doi:10.3390/jcm14010190 .
[30] KUCHARCZYK E, ANDRZEJCZAK K, BILI?SKI K, et al. Iron deficiency in immune-mediated inflammatory skin diseases: A missing link between systemic inflammation, immunometabolism, and disease burden[J]. Cells, 2026, 15(5): 478. doi:10.3390/cells15050478 .
[31] GUO P, KANG R, ZHAO X. Associations between systemic immune-inflammation index and iron deficiency[J]. Sci Rep, 2025, 15: 36182. doi:10.1038/s41598-025-19975-8 .
Outlines

/